Medical cannabis in Mauritius is governed under Part IIIB of the Dangerous Drugs Act, which permits the importation and supply of cannabis-based medicinal products on a named-patient basis. This means products must be prescribed by a licensed medical practitioner and approved for each individual patient through an application process overseen by the Ministry of Health.

 

Cannaheal Ltd is committed to adhering to this patient-centric framework, ensuring that all cannabinoid-based medicines are:

• Prescribed by registered physicians

• Approved by the Ministry of Health on a case-by-case basis

• Imported only through licensed and authorised distribution channels

We work closely with the following government bodies to ensure full regulatory compliance:

• Ministry of Health & Wellness: Oversight and authorisation of medical cannabis applications and patient-specific imports.

• Pharmacy Board of Mauritius: Regulation of pharmaceutical standards and approval of import licensing.

• Mauritius Revenue Authority (Customs): Facilitation of controlled substance imports under strict documentation and traceability.

Our regulatory processes include the submission of:

• Product documentation (GMP certificates, CoAs)

• Import licences and batch-specific authorisations

• Storage and dispensing protocols aligned with national pharmaceutical standards

To ensure safety, efficacy, and traceability, all imported products must:

• Be manufactured under Good Manufacturing Practices (GMP)

• Be accompanied by Certificates of Analysis (CoA)

• Originate from jurisdictions where medical cannabis is legally regulated (e.g., South Africa, Germany, Portugal, Netherlands, etc.)

​

This alignment with international pharmaceutical norms ensures that Mauritian patients benefit from access to high-quality, consistent, and clinically validated medical cannabis products.

Cannaheal Ltd upholds the highest standards of ethical governance, ensuring that all medical cannabis activities are conducted with integrity, accountability, and transparency. We strictly prohibit any promotion or distribution for recreational use, and all products are imported solely for approved medical purposes under physician supervision.

​

We maintain full traceability of every product batch, safeguard patient confidentiality, and comply rigorously with all regulatory requirements. Our commitment is to support a safe, medically guided cannabis ecosystem in Mauritius—one that prioritizes patient care while preventing misuse or diversion.